‌

US Patent 11046771 Monoclonal antibodies against HER2

Patent 11046771 was granted and assigned to Genmab A/S on June, 2021 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

0

Patent attributes

Patent Applicant

0

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Thilo Riedl0

Paul Parren0

Rene Hoet0

Simone De Haij0

Aran Frank Labrijn0

Bart De Goeij0

David Satijn0

Edward N. Van Den Brink0

...

Date of Patent

June 29, 2021

0

Patent Application Number

158323660

Date Filed

December 5, 2017

0

Patent Citations Received

US Patent 11578141 Bispecific antibodies against HER2 and CD3

0

Patent Primary Examiner

0

Patent abstract

Isolated monoclonal antibodies which bind to human epidermal growth factor receptor 2 (HER2), and related antibody-based compositions and molecules, are disclosed. Pharmaceutical compositions comprising the antibodies and therapeutic and diagnostic methods for using the antibodies are also disclosed.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11046771 Monoclonal antibodies against HER2

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.